# Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

> **NCT01005862** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 17 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** PF-04360365
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01005862
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005862, "Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01005862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*